“… 6 , 7 , 9 , 11 , 12 , 16 , 19 , 20 , 21 , 22 Those more likely to originally improve the LV function have a growing body of research identifying the unique demographic and medical profile associated with HFimpEF. 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 16 , 17 , 18 , 19 , 20 , 21 , 22 We assessed longitudinally if those predictive factors remained the same over time or if certain prior comorbidities may be particularly harmful after the demonstration of reverse cardiac remodeling. Similar to others, we identified specific patient characteristics associated with a HFimpEF, including sex, race, and indicators of ischemic damage.…”